First OTC Continuous Blood Glucose Monitor Cleared for Marketing by FDA

WEDNESDAY, March 6, 2024 -- The first over-the-counter continuous glucose monitor (CGM) has been cleared for marketing by the U.S. Food and Drug Administration. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news